Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Apply
REGN5837 & Odronextamab
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step